Cancer startups aren’t exactly underfunded — as a disease area, oncology has commanded investors’ attention for the last decade.
But the American Cancer Society sees gaps.
“Oncology actually is very well-resourced and invested in. The challenge is, is the money going to the areas where there’s the greatest impact?” said Alice Pomponio, the managing director of the society’s venture capital arm, BrightEdge.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
